Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease

Archives of Neurology

Volumn 56, Issue 12, 1999, Pages 1458-1461

  Sabbagh, Mflnvan N ^a   Corey Bloom, Jody ^b   Tiraboschi, Pietro ^c   Thomas, Ronald ^b   Masliah, Eliezer ^a   Thai, Leonj ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c Neurologia Prima   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE; SYNAPTOPHYSIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASSAY; COGNITIVE DEFECT; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; LEWY BODY; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PRIORITY JOURNAL;

EID: 0032713321     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.12.1458     Document Type: Article

References (44)

1. Liebson E, Albert ML Cognitive changes in dementia of the Alzheimer type. In: Calne DB, ed. Neurodegenerative Diseases. Philadelphia, Pa: WB Saunders Co; 1994:615-629.
2. Blessed G, Tomlinson BE, Roth M. The associations between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
3. Wilcock GK, Esiri MM. Plaques, tangles and dementia: a quantitative study. J Neurol Sei. 1982;56:343-356.
4. Neary D, Snowden JS, Mann DM, et al. Alzheimer's disease: a correlative study. J Neurol Neuwsurg Psychiatry. 1986:49:229-237.
5. Martin EM, Wilson RS, Penn RD, Fox MD, Clasen RA, Savoy SM. Cortical biopsy results in Alzheimer's disease: correlation with cognitive deficits. Neurology. 1987; 37:1201-1204.
6. Terry RD, Masliah E, Salmon DP, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol. 1991:30:572-580.
7. Berg L, McKeel DW, Miller P, Baty J, Morris JC. Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. Arch Neurol. 1993;50:349-358.
8. Samuel W, Terry RD, DeTeresa R, Butters N, Masliah E. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. Arch Neurol. 1994; 51:772-778.
9. Cummings BJ, Cotman CW. Image analysis of p-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet. 1995:346:1524-1528.
10. Davies P, Maloney AJF. Selective loss of cholinergic neurons in Alzheimer's disease [letter]. Lancet. 1976;2:1403.
11. Perry EK, Perry RH, Gibson PH, Blessed G, Tomlinson BE. A cholinergic connection between normal aging and senile dementia in the human hippocampus. Neurose! Lett. 1977;6:85-89.
12. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. BMJ. 1978;2:1457-1459.
13. Wilcock GK, Esiri MM, Bowen DM, Smith CC. Alzheimer's disease: correlation of cortical choline acetyltranferase activity with the severity of dementia and histological abnormalities. J Neurol Sei. 1982:57:407-417.
14. Francis PT, Palmer AM, Sims NR, et al. Neurochemical studies of early-onset Alzheimer's disease: possible influence on treatment. NEng/JMed. 1985:313:7-11.
15. Bierer LM, Haroutanian V, Gabriel S, et al. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. JNeurochem. 1995:64:749-760.
16. James JR, Nordberg A. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav Genet. 1995:25:149-159.
17. Nordberg A, Winblad B. Brain nicotinic and muscarinic receptors in normal aging and dementia. In: Fisher A, Hanin I, Lachman C, eds. Alzheimer's and Parkinson's Disease: Strategies for Research and Development. New York, NY: Plenum Press; 1986:95-108.
18. DeKosky ST, Scheff SW. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neural. 1990:27:457-464.
19. Hansen L, Salmon D, Galasko D, et al. The Lev/y body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology. 1990:40:1-8.
20. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lev/y bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996:47:1113-1124.
21. Connor DJ, Salmon DP, Sandy TJ, Galasko D, Hansen LA, Thal LJ. Cognitive profiles of autopsy-confirmed Lev/y body variant vs pure Alzheimer disease. Arch Neural. 1998:55:994-1000.
22. Olichney JM, Galasko D, Salmon DP, et al. Cognitive decline is faster in the Lev/y body variant of Alzheimer's disease. Neurology. 1998:51:351-357.
23. Langlais PJ, Thal L, Hansen L, Galasko D, Alford M, Masliah E. Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and v/ithout Lev/y bodies. Neurology. 1993:43:1927-1934.
24. Hansen LA, Daniel SE, Wilcock GK, Love S. Frontal cortical synaptophysin in Lev/y body diseases: relation to Alzheimer's disease and dementia. J Neural Neurosurg Psychiatry. 1998:64:653-656.
25. Samuel W, Alford M, Hoffstetter CR, Hansen L. Dementia with Lev/y bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J Neuropathol Exp Neurol. 1997;56:499-508.
26. Perry EK, Marshall E, Perry RH, et al. Cholinergic and dopaminergic activities in senile dementia of the Lev/y body type. Alzheimer Dis Assoc Disord. 1990;4:8795.
27. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol. 1985:42:10971105.
28. Mirra SS, Heyman A, McKeel D, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991:41:479-486.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
30. McKhann G, Drachmann D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Neurology. 1984:34:939-944.
31. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
32. Terry R, Peck A, DeTeresa R, Scheeler R, Horoupian DS. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol. 1981 ; 10:184-192.
33. Kuzuhara S, Mori H, Izumiyama N, Yoshimura M, Ihara Y. Lev/y bodies are ubiquinated: a light and electron microscopic immunocytochemical study. Acta Neuropathol (Berl). 1988:75:345-353.
34. Lennox G, Löwe J, Morrell K, Landen M, Mayer RJ. Antiubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lev/y body disease. J Neurol Neurosurg Psychiatry. 1989:52:67-71.
35. Fonnum F. Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase and acetylcholinesterase activities. Biochemj. 1969:115:465-472.
36. Hansen LA, DeTeresa R, Tobias H, Alford M, Terry RD. Neocortical morphometry and cholinergic neurochemistry in Pick's disease. Am J Pathol. 1988;131 : 507-518.
37. Hansen LA, DeTeresa R, Davies P, Terry RD. Neocortical morphometry, lesion counts, and choline acetyltransferase levels in the age spectrum of Alzheimer's disease. Neurology. 1988:38:48-54.
38. Alford MF, Masliah E, Hansen LA, Terry RD. A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain. JH/stochem Cytochem. 1994:42:283-287.
39. Neary D, Snowden JS, Bowen DM, et al. Neuropsychological syndromes in presenile dementia due to cerebral atrophy. J Neurol Neurosurg Psychiatry. 1986; 49:163-174.
40. Carroll PT. Membrane-bound choline-O-acetyltransferase in rat hippocampal tissue is associated v/ith synaptic vesicles. Brain Res. 1994;633:112-118.
41. de la Torre JC, Goldsmith HS. Supraspinal fiber outgrowth and apparent synaptic remodelling across transected-reconstructed feline spinal cord. Acta Neurochir(Wien). 1992;114:118-127.
42. Torack RM, Miller JW. Denervation induced abnormal phosphorylation in hippocampal neurons. Brain Res. 1995:669:135-139.
43. Romijn HJ, van Marie J, Janszen AW. Permanent increase of the GAD67/ synaptophysin ratio in rat cerebral cortex nerve endings as a result of hypoxic ischémie encephalopathy sustained in early postnatal life: a confocal laser scanning microscopic study. Brain Res. 1993:630:315-329.
44. Gomez-lsla T, Growdon W, McNamara M, Growdon JH, Hyman BT. Diffuse Lev/y body dementia: quantitative neuropathological studies and APOE genotyping [abstract]. Neurology. 1997;48:A140-A141.